A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo

Wu Y.-W.Chao M.-W.Tu H.-J.Chen L.-C.Hsu K.-C.Liou J.-P.CHIA-RON YANGYen S.-C.HuangFu W.-C.Pan S.-L.2021-06-042021-06-04202121579024https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105782694&doi=10.1038%2fs41389-021-00331-0&partnerID=40&md5=b0460d5fa0922e89931ed755d0c0b6behttps://scholars.lib.ntu.edu.tw/handle/123456789/565261A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivojournal article10.1038/s41389-021-00331-02-s2.0-85105782694